1. Home
  2. OPBK vs MOLN Comparison

OPBK vs MOLN Comparison

Compare OPBK & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPBK
  • MOLN
  • Stock Information
  • Founded
  • OPBK 2005
  • MOLN 2004
  • Country
  • OPBK United States
  • MOLN Switzerland
  • Employees
  • OPBK N/A
  • MOLN N/A
  • Industry
  • OPBK Major Banks
  • MOLN
  • Sector
  • OPBK Finance
  • MOLN
  • Exchange
  • OPBK Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • OPBK 196.5M
  • MOLN 157.8M
  • IPO Year
  • OPBK 2018
  • MOLN 2021
  • Fundamental
  • Price
  • OPBK $13.10
  • MOLN $4.07
  • Analyst Decision
  • OPBK Buy
  • MOLN Hold
  • Analyst Count
  • OPBK 2
  • MOLN 1
  • Target Price
  • OPBK $16.50
  • MOLN $4.00
  • AVG Volume (30 Days)
  • OPBK 39.7K
  • MOLN 11.0K
  • Earning Date
  • OPBK 10-23-2025
  • MOLN 10-30-2025
  • Dividend Yield
  • OPBK 3.66%
  • MOLN N/A
  • EPS Growth
  • OPBK 13.19
  • MOLN N/A
  • EPS
  • OPBK 1.58
  • MOLN N/A
  • Revenue
  • OPBK $87,081,000.00
  • MOLN N/A
  • Revenue This Year
  • OPBK $22.24
  • MOLN N/A
  • Revenue Next Year
  • OPBK $10.31
  • MOLN $1,000.00
  • P/E Ratio
  • OPBK $8.30
  • MOLN N/A
  • Revenue Growth
  • OPBK 10.57
  • MOLN N/A
  • 52 Week Low
  • OPBK $10.43
  • MOLN $3.36
  • 52 Week High
  • OPBK $18.57
  • MOLN $5.99
  • Technical
  • Relative Strength Index (RSI)
  • OPBK 46.87
  • MOLN 50.81
  • Support Level
  • OPBK $12.63
  • MOLN $3.98
  • Resistance Level
  • OPBK $13.31
  • MOLN $4.32
  • Average True Range (ATR)
  • OPBK 0.26
  • MOLN 0.33
  • MACD
  • OPBK -0.03
  • MOLN -0.02
  • Stochastic Oscillator
  • OPBK 49.84
  • MOLN 33.98

About OPBK OP Bancorp

OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: